NCT06408350

Brief Summary

Text Me, Alexis! is a three-arm randomized controlled trial (RCT) to determine the optimal and most cost-effective intervention for advancing trans women living with HIV to full viral suppression. Participants will be randomized (1:1:1) to Peer Health Navigation (PHN) alone, SMS (text messaging) alone, or PHN+SMS. Participants in the PHN alone and PHN+SMS arms will receive unlimited navigation sessions over 3 months. Participants in the SMS alone and PHN+SMS arms will receive 3 daily theory-based text messages for 90 days for a total of 270 unique scripted messages.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P25-P50 for not_applicable hiv

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2024

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

April 26, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 10, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 19, 2025

Completed
Last Updated

February 11, 2026

Status Verified

May 1, 2025

Enrollment Period

11 months

First QC Date

April 26, 2024

Last Update Submit

February 9, 2026

Conditions

Keywords

HIVtransgender womenpeer health navigationSMS, text messagingeconomic evaluation

Outcome Measures

Primary Outcomes (2)

  • Rate of HIV Viral Load Suppression

    HIV virological suppression is defined as the undetectability threshold ˂200 copies/mL. Key indicators of HIV care will be regressed on treatment condition and a series of baseline and time-varying covariates. Responses at each timepoint will be considered nested within an individual, which is necessary to control for the violations of independence that can occur when repeated measurements are taken from the same individual.

    18 months

  • Relative Cost Effectiveness

    The primary outcome of the cost-effectiveness analysis is the incremental cost-effectiveness ratio (ICER), which will be calculated as the incremental mean cost of a given intervention relative to an alternative, divided by the incremental mean effectiveness of the two interventions. Two types of ICERs will be calculated, one for each measure of effectiveness: a) The quality-adjusted life-year (QALY) is a measure that combines the health-related quality-of-life (HRQoL) associated with an individual's health state and their time spent in that state, and b) Advancement along the HIV Care Continuum. All measures of mean cost and effectiveness will be adjusted for important covariates. Relative cost-effectiveness will be assessed according to multiple decision-maker perspectives, and will be evaluated across a range of willingness-to-pay thresholds.

    18 months

Secondary Outcomes (1)

  • Measurements of Heterogeneous Intervention Effects

    18 months

Study Arms (3)

Peer Health Navigation (PHN)

EXPERIMENTAL

PHN is a peer navigation intervention to advance trans women through the HIV Care Continuum by identifying their individual needs and barriers to HIV care, including: substance use and behavioral health needs; adherence goal(s); and methods to achieve adherence. Participants receive unlimited navigation sessions over 3 months; PHN sessions are delivered in a private room similar to a one-on-one peer counseling session.

Behavioral: Text Me, Alexis!

Simple Message System (SMS [text messaging])

EXPERIMENTAL

Text messages are scripted across: 1) HIV Care Continuum (HIV Positivity/Physical and Emotional Health, Linkage/Retention in HIV Care, and ART Adherence/Viral Load Suppression); and, 2) theoretical foundation (Social Support Theory, Social Cognitive Theory, or Health Belief Model). Participants receive three daily, theory-based text messages for 90 days (270 unique scripted messages), evenly arrayed across the HIV Care Continuum. Text messages are delivered and transmitted to either a cell phone or an email inbox.

Behavioral: Text Me, Alexis!

PHN and SMS

EXPERIMENTAL

PHN + SMS is the combined intervention. PHN is a peer navigation intervention to advance trans women through the HIV Care Continuum by identifying their individual needs and barriers to HIV care, including: substance use and behavioral health needs; adherence goal(s); and methods to achieve adherence. Participants receive unlimited navigation sessions over 3 months; PHN sessions are delivered in a private room similar to a one-on-one peer counseling session. Text messages are scripted across: 1) HIV Care Continuum (HIV Positivity/Physical and Emotional Health, Linkage/Retention in HIV Care, and ART Adherence/Viral Load Suppression); and, 2) theoretical foundation (Social Support Theory, Social Cognitive Theory, or Health Belief Model). Participants receive three daily, theory-based text messages for 90 days (270 unique scripted messages), evenly arrayed across the HIV Care Continuum. Text messages are delivered and transmitted to either a cell phone or an email inbox.

Behavioral: Text Me, Alexis!

Interventions

Determine the Optimal Intervention for Advancing Transgender Women Living with HIV to Full Viral Suppression

PHN and SMSPeer Health Navigation (PHN)Simple Message System (SMS [text messaging])

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsSelf-identified Transgender Woman
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-identified transgender woman;
  • Age 18 or older;
  • Verified HIV positive status;
  • Not currently in HIV care, and/or had not had an HIV care visit in the previous 6 months, and/or had a viral load of ≥200 copies/ml on her last lab test result, and/or not currently prescribed ART, and/or prescribed ART but does not rate her ability to take all her medications as "excellent";
  • Ability to receive daily text messages on either a personal cell phone or via an email account

You may not qualify if:

  • Does not identify as a transgender woman;
  • Under 18 years of age;
  • HIV negative status;
  • Currently in HIV care, and had a HIV care visit in the previous 6 months, and had a viral load of ≤200 copies/ml on her last lab test result, and currently prescribed ART, and rates her ability to take all her medications as "excellent";
  • Does not have the ability to receive daily text messages on either a personal cell phone or via an email account.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Friends Community Center

Los Angeles, California, 90028, United States

Location

Study Officials

  • Cathy J Reback, PhD

    Friends Research Institute, Inc.

    PRINCIPAL INVESTIGATOR
  • Sean M Murphy, PhD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three randomly assigned arms.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2024

First Posted

May 10, 2024

Study Start

April 11, 2024

Primary Completion

March 19, 2025

Study Completion

March 19, 2025

Last Updated

February 11, 2026

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

No current plan to share individual participant data.

Locations